BlackRock’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-127,743
| Closed | -$501K | – | 5449 |
|
|
2023
Q3 | $501K | Buy |
127,743
+74,204
| +139% | +$291K | ﹤0.01% | 4359 |
|
|
2023
Q2 | $174K | Sell |
53,539
-4,231
| -7% | -$13.8K | ﹤0.01% | 4679 |
|
|
2023
Q1 | $209K | Sell |
57,770
-3,864
| -6% | -$14K | ﹤0.01% | 4673 |
|
|
2022
Q4 | $1.98M | Buy |
61,634
+1,366
| +2% | +$44K | ﹤0.01% | 4061 |
|
|
2022
Q3 | $2.52M | Buy |
60,268
+14,720
| +32% | +$615K | ﹤0.01% | 3987 |
|
|
2022
Q2 | $1.92M | Sell |
45,548
-57,662
| -56% | -$2.43M | ﹤0.01% | 4178 |
|
|
2022
Q1 | $7M | Sell |
103,210
-2,157
| -2% | -$146K | ﹤0.01% | 3698 |
|
|
2021
Q4 | $12.8M | Buy |
105,367
+13,354
| +15% | +$1.62M | ﹤0.01% | 3462 |
|
|
2021
Q3 | $13M | Sell |
92,013
-162
| -0.2% | -$22.8K | ﹤0.01% | 3504 |
|
|
2021
Q2 | $25.3M | Buy |
92,175
+10,688
| +13% | +$2.94M | ﹤0.01% | 3102 |
|
|
2021
Q1 | $17.4M | Buy |
81,487
+16,474
| +25% | +$3.53M | ﹤0.01% | 3197 |
|
|
2020
Q4 | $15.7M | Buy |
65,013
+18,082
| +39% | +$4.37M | ﹤0.01% | 3069 |
|
|
2020
Q3 | $4.95M | Buy |
46,931
+5,880
| +14% | +$620K | ﹤0.01% | 3485 |
|
|
2020
Q2 | $4.02M | Buy |
41,051
+2,394
| +6% | +$235K | ﹤0.01% | 3535 |
|
|
2020
Q1 | $2.9M | Buy |
38,657
+954
| +3% | +$71.6K | ﹤0.01% | 3481 |
|
|
2019
Q4 | $3.06M | Buy |
37,703
+94
| +0.2% | +$7.63K | ﹤0.01% | 3596 |
|
|
2019
Q3 | $4.59M | Buy |
37,609
+4,871
| +15% | +$594K | ﹤0.01% | 3468 |
|
|
2019
Q2 | $5.88M | Buy |
32,738
+426
| +1% | +$76.5K | ﹤0.01% | 3443 |
|
|
2019
Q1 | $5.17M | Sell |
32,312
-1,235
| -4% | -$198K | ﹤0.01% | 3362 |
|
|
2018
Q4 | $8.73M | Buy |
33,547
+20,520
| +158% | +$5.34M | ﹤0.01% | 3150 |
|
|
2018
Q3 | $3.17M | Sell |
13,027
-60
| -0.5% | -$14.6K | ﹤0.01% | 3580 |
|
|
2018
Q2 | $3.09M | Buy |
+13,087
| New | +$3.09M | ﹤0.01% | 3567 |
|